Cargando…
Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA
BACKGROUND: Hepatitis C virus (HCV), a member of the Flaviviridae family of viruses, is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Currently, the only treatment available consists of a combination of Pegylated interferon alpha (INF-α) and ribavirin, but only ha...
Autores principales: | Ansar, Muhammad, Ashfaq, Usman Ali, shahid, Imran, Sarwar, Muhammad Tahir, Javed, Tariq, Rehman, Sidra, Hassan, Sajida, Riazuddin, Sheikh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094304/ https://www.ncbi.nlm.nih.gov/pubmed/21535893 http://dx.doi.org/10.1186/1743-422X-8-203 |
Ejemplares similares
-
Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA
por: Ali Ashfaq, Usman, et al.
Publicado: (2011) -
Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells
por: Rehman, Sidra, et al.
Publicado: (2011) -
In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
por: Javed, Tariq, et al.
Publicado: (2011) -
Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
An overview of HCV molecular biology, replication and immune responses
por: Ashfaq, Usman A, et al.
Publicado: (2011)